PRF Technologies shares surge 35.51% after-hours as rebranding to reflect expanded healthcare and AI-driven energy portfolio fuels investor optimism.

PainReform (PRFX) surged 35.51% in after-hours trading following its announcement to rebrand as PRF Technologies Ltd., signaling a strategic expansion into specialty pharmaceuticals, ophthalmic therapies, and AI-driven renewable energy analytics. The name change aligns with the company’s broadened portfolio, including its non-opioid pain therapy PRF-110 and ocular treatment OcuRing-K, while also diversifying into energy analytics via DeepSolar. Trading volume spiked to 35.49 million shares, far exceeding its average of 672,850, reflecting heightened market interest in the rebranded entity’s growth narrative. The move underscores investor optimism about the firm’s reduced reliance on single-product outcomes and its pivot toward a diversified platform, as highlighted in multiple news reports citing the rebranding as the primary catalyst for the post-market rally.